BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $852,804 | +252.1% | 121,137 | +474.1% | 0.01% | +250.0% |
| Q4 2022 | $242,228 | -90.8% | 21,100 | -89.9% | 0.00% | -90.9% |
| Q3 2022 | $2,621,000 | +44.6% | 207,972 | +21.4% | 0.02% | +22.2% |
| Q2 2022 | $1,813,000 | -61.2% | 171,296 | -40.5% | 0.02% | -57.1% |
| Q1 2022 | $4,678,000 | +534.7% | 287,700 | +440.8% | 0.04% | +500.0% |
| Q4 2021 | $737,000 | +74.2% | 53,200 | +80.6% | 0.01% | +75.0% |
| Q3 2021 | $423,000 | -74.5% | 29,459 | -72.0% | 0.00% | -77.8% |
| Q2 2021 | $1,661,000 | +726.4% | 105,087 | +433.3% | 0.02% | +800.0% |
| Q1 2021 | $201,000 | -69.1% | 19,704 | -77.5% | 0.00% | -77.8% |
| Q4 2020 | $650,000 | -21.7% | 87,391 | -63.8% | 0.01% | -43.8% |
| Q3 2020 | $830,000 | -47.9% | 241,411 | -27.8% | 0.02% | -23.8% |
| Q2 2020 | $1,594,000 | +16.4% | 334,456 | -15.8% | 0.02% | -36.4% |
| Q4 2019 | $1,370,000 | -47.5% | 397,266 | -56.4% | 0.03% | -57.1% |
| Q3 2019 | $2,611,000 | -69.2% | 911,300 | -59.2% | 0.08% | -74.2% |
| Q2 2019 | $8,467,000 | +9413.5% | 2,233,700 | +20206.4% | 0.30% | +9866.7% |
| Q4 2018 | $89,000 | -78.7% | 11,000 | -79.9% | 0.00% | -84.2% |
| Q3 2018 | $418,000 | +450.0% | 54,800 | +299.3% | 0.02% | +137.5% |
| Q2 2017 | $76,000 | -88.2% | 13,723 | -82.1% | 0.01% | -87.5% |
| Q1 2017 | $643,000 | – | 76,583 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |